Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies

Authors:

Abstract
No abstract available
Funding Information
  • Leukemia and Lymphoma Society

This publication has 54 references indexed in Scilit: